XML 25 R14.htm IDEA: XBRL DOCUMENT
v3.21.1

STOCK COMPENSATION PLAN | 3 Months Ended
--- | ---
Mar. 31, 2021
STOCK COMPENSATION PLAN |
STOCK COMPENSATION PLAN | NOTE 7 - STOCK COMPENSATION PLAN Equity Incentive Plan On May 28, 2019, the Company's 2019 Equity Incentive Plan (the “2019 EIP”) was approved by stockholders of the Company. Under the 2019 EIP, the maximum number of shares of stock that may be delivered to participants in the form of restricted stock, restricted stock units and stock options, including incentive stock options (“ISO”) and non-qualified stock options, is 340,000, plus any awards that are forfeited under the 2009 Equity Incentive Plan (the “2009 Plan”) after the effective date of the 2019 EIP, which was May 28, 2019. Under the 2009 Plan, there are 468,382 shares that are subject to outstanding and/or unexercised awards that have been granted and, if forfeited after May 28, 2019, such shares will be available to be granted under the 2019 EIP. The 628,719 shares that were unauthorized and unissued under the 2009 Plan have expired and may not be granted (and such shares of stock did not roll over to the 2019 EIP). Under the terms of the 2019 EIP, a stock option cannot have an exercise price that is less than 100% of the fair market value of the shares covered by the stock option on the date of grant. In the case of an ISO granted to a 10% stockholder, the exercise price shall not be less than 110% of the fair market value of the shares covered by the stock option on the date of grant. In no event shall the exercise period exceed ten years from the date of grant of the option, except, in the case of an ISO granted to a 10% stockholder, the exercise period shall not exceed five years from the date of grant. The 2019 EIP contains a double trigger change in control feature, providing for an acceleration of vesting upon an involuntary termination of employment simultaneous with or following a change in control. The fair value of each stock option award is estimated on the date of grant using a closed form option valuation (Black-Scholes) model. Expected volatilities based on historical volatilities of the Company’s common stock are not significant. The expected term of options granted is based on historical data and represents the period of time that options granted are expected to be outstanding, which takes into account that the options are not transferable. The risk-free interest rate for the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of the grant. A summary of the status of the Company’s stock options and the changes during the three months ended March 31, 2021 is presented below: ​
​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended March 31, 2021
​ |  | Number of |  | Weighted Average
​ | ​ | Options | ​ | Exercise Price
​ | ​ | ​ | ​ | ​ | ​
Outstanding, beginning of period | ​ | 231,000 | ​ | $ | 18.00
Granted | ​ | — | ​ | ​ | —
Exercised | ​ | — | ​ | ​ | —
Cancelled/forfeited | ​ | — | ​ | ​ | —
Outstanding, end of period | ​ | 231,000 | ​ | $ | 18.00
Options vested and exercisable at end of period | ​ | 231,000 | ​ | $ | 18.00
​ | ​ | ​ | ​ | ​ | ​
Weighted average remaining contractual life (years) | ​ | ​ | ​ | ​ | 3.13
​ There was no unrecognized compensation cost related to stock options at March 31, 2021 or December 31, 2020. There was no compensation cost related to stock options for the three months ended March 31, 2021 and 2020. The following table summarizes information about stock options outstanding at March 31, 2021: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | At March 31, 2021
Range of Average | ​ | ​ | ​ | Weighted Average | ​ | Weighted Average | ​ | Weighted Average
Exercise Prices |  | Number Outstanding at |  | Remaining Contractual Life |  | Exercise Price | ​ | Intrinsic Price per Share
$10 – 20 | ​ | 231,000 | ​ | 3.13 | ​ | $ | 18.00 | ​ | $ | 32.36
$10 – 30 | ​ | 231,000 | ​ | 3.13 | ​ | $ | 18.00 | ​ | $ | 32.36
​ ​ There were no stock options exercised during the three months ended March 31, 2021. Restricted Stock Awards and Restricted Stock Units The Company issued restricted stock awards under the 2009 Plan and restricted stock units under the 2019 EIP (collectively, “restricted stock grants”) to certain key personnel. Each restricted stock grant vests based on the vesting schedule outlined in the restricted stock grant agreement. Restricted stock grants are subject to forfeiture if the holder is not employed by the Company on the vesting date. In the first quarter of 2021, 78,582 restricted stock units were issued to certain key personnel. One-third of these shares vest each year for three years beginning on March 1, 2022. Total compensation cost that has been charged against income for restricted stock grants was $476,000 and $354,000 for the three months ended March 31, 2021 and 2020, respectively. As of March 31, 2021, there was $5.7 million of total unrecognized compensation expense related to the restricted stock awards. The cost is expected to be recognized over a weighted-average period of 2.46 years. Additionally, on January 1, 2019, 38,900 restricted shares were granted to members of the Board of Directors in lieu of retainer fees for three years of service. One-third of these shares vest each year for three years beginning on December 31, 2019. In the fourth quarter of 2020, 1,785 shares were granted to a new member of the Board of Directors, all of which will vest in the fourth quarter of 2021. Total expense for these awards was $110,000 and $100,000 for the three months ended March 31, 2021 and 2020, respectively. As of March 31, 2021, there was $330,000 of unrecognized expense related to these grants. The cost is expected to be recognized over a weighted-average period of 0.75 years. The following table summarizes the changes in the Company’s restricted stock grants for the three months ended March 31, 2021: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended March 31, 2021 | ​
​ | ​ | ​ | ​ | Weighted Average | ​
​ |  | Number of Shares |  | Grant Date Fair Value | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
Outstanding, beginning of period | ​ | 76,289 | ​ | $ | 37.01 | ​
Granted | ​ | 78,582 | ​ | ​ | 50.80 | ​
Forfeited | ​ | (739) | ​ | ​ | 48.80 | ​
Vested | ​ | (12,728) | ​ | ​ | 28.25 | ​
Outstanding at end of period | ​ | 141,404 | ​ | $ | 45.40 | ​
​ The total fair value of shares vested was $360,000 for the three months ended March 31, 2021. Performance Based Stock Awards During the first quarter of 2018, the Company established a long-term incentive award program under the 2009 Plan. For each award, Performance Restricted Share Units (“PRSUs”) are eligible to be earned over a three-year performance period based on personal performance and the Company’s relative performance, in each case, as compared to certain measurement goals that were established at the onset of the performance period. These awards were accounted for in accordance with guidance prescribed in ASC Topic 718, Compensation – Stock Compensation. 90,000 PRSUs were awarded under the program. The PRSUs were earned at the end of the three-year period and vested in the first quarter of 2021. There was no compensation cost that has been charged against income for these PRSUs for the three months ended March 31, 2021 since the entire expense of the grants was charged against income over the three-year performance period. Total compensation cost that has been charged against income for this program was $358,000 for the three months ended March 31, 2020. ​ No PRSUs were granted in the first quarter of 2021.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration